> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears K2M’s New Cascadia Spinal Implant
- URL: https://www.fdaweb.com/fda-clears-k2ms-new-cascadia-spinal-implant/
- Published: 2016-01-11T12:00:00.000Z
- Updated: 2026-09-15T02:26:26.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5134396

> FDA has cleared a K2M Group Holdings 510(k) for the Cascadia Lateral Interbody System featuring Lamellar Titanium Technology that uses 3D printing with the goal of allowing for bony integration throughout the spinal implant. “Starting with a titanium powder, the implants are grown through the selective application of a high-energy laser beam, allowing for the incorporation of both a porosity and surface roughness that pre-clinical data have associated with bone growth activity,” the company says.  
>  
> The device features a reverse hourglass implant design that allows for increased endplate contact compared to K2M’s Aleutian implant. The system includes a full range of implant sizes and is designed to work in conjunction with the Ravine Lateral Access System, which the company says offers a full line of instrumentation for the far lateral transpsoas approach.